DERMA SCIENCES, INC. 4
4 · DERMA SCIENCES, INC. · Filed Feb 19, 2014
Insider Transaction Report
Form 4
Wolfenson Barry
VP - Marketing & Bus. Dev.
Transactions
- Award
Common Stock
2014-02-14+4,500→ 63,835 total - Award
Stock Option (right to buy)
2014-02-14+15,500→ 15,500 totalExercise: $11.97From: 2014-02-14Exp: 2023-02-13→ Common Stock (15,500 underlying) - Award
Stock Option (right to buy)
2014-02-14+23,500→ 23,500 totalExercise: $13.39From: 2014-02-14Exp: 2024-02-14→ Common Stock (23,500 underlying)
Footnotes (3)
- [F1]The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 4,500 restricted stock units.
- [F2]The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 15,500 options.
- [F3]The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date and will vest as to an additional 25% on February 14 of 2015, 2016 and 2017.